story of the week
Upfront Chemotherapy With Trastuzumab in Patients With HER2-Positive Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Annals of Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Do All Patients With Advanced HER2 Positive Breast Cancer Need Upfront-Chemo When Receiving Trastuzumab? Randomized Phase III Trial SAKK 22/99
Ann. Oncol 2016 Dec 19;[EPub Ahead of Print], O Pagani, D Klingbiel, T Ruhstaller, F Nolè, S Eppenberger, C Oehlschlegel, J Bernhard, P Brauchli, D Hess, C Mamot, E Munzone, B Pestalozzi, M Rabaglio, S Aebi, K Ribi, C Rochlitz, K Rothgiesser, B Thürlimann, RV Moos, K Zaman, A GoldhirschFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.